Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma

NCT01011920 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

227

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Lymphoma

Interventions

DRUG: Methotrexate
DRUG: Ara-C
DRUG: Rituximab
DRUG: Thiotepa
RADIATION: radiotherapy
DRUG: BCNU
OTHER: APBSCT

Sponsor

International Extranodal Lymphoma Study Group (IELSG)